About the Authors
- Manuel A. Silva
-
Roles Conceptualization, Methodology, Writing – original draft
* E-mail: manuel_agustin.silva_munoz@boehringer-ingelheim.com
Affiliation Department of Translational Medicine and Clinical Pharmacology, Boehringer-Ingelheim GmbH, Ingelheim am Rhein, Hesse, Germany
- Shuntae Williams
-
Roles Data curation, Methodology, Resources, Validation, Writing – review & editing
Affiliation Hematogenix, Chicago, Illinois, United States of America
- Sylvie Hauert
-
Roles Data curation, Methodology, Validation, Writing – review & editing
Affiliation Hematogenix, Chicago, Illinois, United States of America
- Benjamin Ovadia
-
Roles Data curation, Formal analysis, Validation, Writing – review & editing
Affiliation NeoGenomics, Fort Myers, Florida, United States of America
- Indu Gupta
-
Roles Data curation, Formal analysis
Affiliation NeoGenomics, Fort Myers, Florida, United States of America
- Lorenz Waldmeier
-
Roles Investigation, Methodology, Validation, Writing – review & editing
Affiliation NBE Therapeutics AG, Basel, Switzerland
- Yarúa Jaimes
-
Roles Data curation, Methodology, Validation
Affiliation Department of Translational Medicine and Clinical Pharmacology, Boehringer-Ingelheim GmbH, Ingelheim am Rhein, Hesse, Germany
- Hytham Al-Masri
-
Roles Formal analysis, Writing – review & editing
Affiliation Hematogenix, Chicago, Illinois, United States of America
Competing Interests
This work was funded by Boehringer-Ingelheim GmbH, the employer of Manuel A. Silva, Lorenz Waldmeier and Yarúa Jaimes. Shuntae Williams, Sylvie Hauert, and Hytham Al-Masri are employed by Hematogenix. Benjamin Ovadia and Indu Gupta are employed by NeoGenomics. There are no patents, products in development or marketed products to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.